Literature DB >> 16476494

A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists.

Vincenzo Di Marzo1.   

Abstract

British scientists have played a leading role in the long history of cannabinoid and endocannabinoid research. Such research has progressed from the first crucial evaluation of the medicinal properties of Cannabis sativa in the Western world to pioneering studies of the chemical constituents of this plant, the development of in vitro biological assays to study cannabinoids, the identification of the mechanism of action of cannabinoids, the discovery of endocannabinoids and the assessment of their therapeutic implications. Stemming from the many innovative ideas and achievements of these researchers, I provide a personal view of where these studies have led us thus far and where they are likely to take us in the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476494     DOI: 10.1016/j.tips.2006.01.010

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  25 in total

Review 1.  Therapeutic potential of monoacylglycerol lipase inhibitors.

Authors:  Melinda M Mulvihill; Daniel K Nomura
Journal:  Life Sci       Date:  2012-11-08       Impact factor: 5.037

Review 2.  2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook.

Authors:  Anita Hermann; Martin Kaczocha; Dale G Deutsch
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

Review 3.  Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?

Authors:  Kathryn A Seely; Paul L Prather; Laura P James; Jeffery H Moran
Journal:  Mol Interv       Date:  2011-02

4.  Canadian dog owners' use and perceptions of cannabis products.

Authors:  Lori R Kogan; Peter W Hellyer; Sarah Silcox; Regina Schoenfeld-Tacher
Journal:  Can Vet J       Date:  2019-07       Impact factor: 1.008

5.  From "Azalla" to Anandamide: Distilling the Therapeutic Potential of Cannabinoids.

Authors:  Rajiv Radhakrishnan; David A Ross
Journal:  Biol Psychiatry       Date:  2018-01-15       Impact factor: 13.382

6.  Identification by nuclear magnetic resonance spectroscopy of an active-site hydrogen-bond network in human monoacylglycerol lipase (hMGL): implications for hMGL dynamics, pharmacological inhibition, and catalytic mechanism.

Authors:  Ioannis Karageorgos; Sergiy Tyukhtenko; Nikolai Zvonok; David R Janero; Christine Sallum; Alexandros Makriyannis
Journal:  Mol Biosyst       Date:  2010-05-12

7.  Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol.

Authors:  Maria Valeria Catani; Filomena Fezza; Samantha Baldassarri; Valeria Gasperi; Alessandra Bertoni; Nicoletta Pasquariello; Alessandro Finazzi-Agrò; Fabiola Sinigaglia; Luciana Avigliano; Mauro Maccarrone
Journal:  J Mol Med (Berl)       Date:  2008-09-27       Impact factor: 4.599

Review 8.  Recent advances in the pharmacological management of pain.

Authors:  Josée Guindon; Jean-Sébastien Walczak; Pierre Beaulieu
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.

Authors:  Viviana Trezza; Ruth Damsteegt; Antonia Manduca; Stefania Petrosino; Linda W M Van Kerkhof; R Jeroen Pasterkamp; Yeping Zhou; Patrizia Campolongo; Vincenzo Cuomo; Vincenzo Di Marzo; Louk J M J Vanderschuren
Journal:  J Neurosci       Date:  2012-10-24       Impact factor: 6.167

10.  Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells.

Authors:  Monica Bari; Sergio Oddi; Chiara De Simone; Paola Spagnolo; Valeria Gasperi; Natalia Battista; Diego Centonze; Mauro Maccarrone
Journal:  Neuropharmacology       Date:  2007-07-20       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.